Payment Link for Sterlitech Corporation - Track etched Membrane Market & Pharmaceutical Filtration Market
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
 |
Porcine parvovirus Porcine parvovirus and Porcine Circovirus II, Swine... |
Upcoming |
|
|
Porcine Circovirus II Porcine Circovirus II and Porcine parvovirus, Swine Influenza,... |
Upcoming |
|
|
Swine Influenza Swine Influenza and Porcine parvovirus, Porcine Circovirus... |
Upcoming |
|
|
Swine pneumonia Swine pneumonia and Porcine parvovirus, Porcine Circovirus... |
Upcoming |
|
|
Porcine Reproductive Respiratory Syndrome (PRRS) Porcine Reproductive Respiratory Syndrome (PRRS) and Porcine parvovirus, |
Upcoming |
|
|
Equine Encephalomyelitis Equine Encephalomyelitis and Strangles, Equine Influenza, |
Upcoming |
|
|
Strangles Strangles and Equine Encephalomyelitis, Equine... |
Upcoming |
|
|
Equine Influenza Equine Influenza and Equine Encephalomyelitis, Strangles, |
Upcoming |
|
|
Equine Rhinopneumonitis Equine Rhinopneumonitis and Equine Encephalomyelitis, |
Upcoming |
|
|
Vibriosis Vibriosis and Pasteurellosis, Furunculosis and |
Upcoming |
|
|
Pasteurellosis Pasteurellosis and Vibriosis, Furunculosis and |
Upcoming |
|
|
Furunculosis Furunculosis and Vibriosis, Pasteurellosis and |
Upcoming |
|
|
Lutienizing Hormone-Releasing Hormone (LHRH) Antagonists Lutienizing Hormone-Releasing Hormone (LHRH) Antagonists and Lutienizing Hormone-Releasing Hormone (LHRH) Analogs and |
Upcoming |
|
|
Lutienizing Hormone-Releasing Hormone (LHRH) Analogs Lutienizing Hormone-Releasing Hormone (LHRH) Analogs and Lutienizing Hormone-Releasing Hormone (LHRH) Antagonists and |
Upcoming |
|
|
Anti-Androgens Anti-Androgens and Lutienizing Hormone-Releasing Hormone (LHRH) Antagonists and |
Upcoming |
|
|
Phase III (Immunotherapy) Phase III (Immunotherapy) and Phase I (Immunotherapy) and |
Upcoming |
|
|
Phase III (Targeted Therapy) Phase III (Targeted Therapy) and Phase I (Targeted Therapy) and |
Upcoming |
|
|
Phase III (Hormonal Therapy) Phase III (Hormonal Therapy) and Phase I (Hormonal Therapy) and |
Upcoming |
|
|
North America Live attenuated vaccines The North American Live attenuated Animal Vaccine Market is mainly driven by growing prevalence of Animal Diseases and increasing incidences of Zoonotic diseases in humans. It was pegged at $805 million in 2013 and expected to be $999 million by 2018 at a CAGR of 4.4%. Live attenuated Animal Vaccine Market analyzes the market by 6 Products such as Aquaculture, Companion animal vaccines, Equine, Livestock, Porcine, and Poultry. The prominent players in the Market are Sanofi Aventis, Merck, Pfizer, Bayer, and Virbac. |
Upcoming |
|
|
European Live attenuated vaccines Market The European Live attenuated Animal Vaccine Market is mainly driven by growing prevalence of Animal Diseases and increasing incidences of Zoonotic diseases in humans. It was pegged at $956 million in 2013 and expected to be $1253 million by 2018 at a CAGR of 5.6%. Live attenuated Animal Vaccine Market analyzes the market by 6 Products such as Aquaculture, Companion animal vaccines, Equine, Livestock, Porcine, and Poultry. The prominent players in the Market are Sanofi Aventis, Merck, Pfizer, Bayer, and Virbac. |
Upcoming |
Payment Link for Sterlitech Corporation - Track etched Membrane Market & Pharmaceutical Filtration Market
